|
1 |
17 02 2026 |
India-EFTA to discuss pharma, biotech ties for global supply chains |
Newable Asianet News |
India |
|
2 |
17 02 2026 |
UP Pharma & Medical Devices Industry Policy to boost R&D, clinical research & export: Experts |
Pharmabiz |
India |
|
3 |
17 02 2026 |
UIPSR & BFUHS celebrate GWB-2026 by empowering female leadership in pharmaceutical sciences |
Pharmabiz |
India |
|
4 |
17 02 2026 |
Institutions including CDSCO under ministry of health to witness 11% higher allocation under BE 2026-27 |
Pharmabiz |
India |
|
5 |
17 02 2026 |
Maharashtra FDA cancels licenses of 27 & suspends licenses of 94 units for non-compliance to D&C Act |
Pharmabiz |
India |
|
6 |
17 02 2026 |
Natco Pharma shares surge over 10% on getting nod for diabetes drug Semaglutide in India |
Up Stox |
India |
|
7 |
16 02 2026 |
Government reaffirms NPPA Stent Price Caps, States tasked with Curbing Hospital overcharging. |
|
India |
|
8 |
16 02 2026 |
Alkem arm makes binding offer to acquire 51-55% stake in Swiss MedTech firm Occlutech |
Medical Dialogues |
India |
|
9 |
16 02 2026 |
Aurobindo arm Acrotech secure USFDA nod for Atopic Dermatitis Drug ADQUEY |
Medical Dialogues |
India |
|
10 |
16 02 2026 |
DoP issues draft revised list of 354 medical devices exempt for Global procurement ,invites stakeholder input |
Medical Dialogues |
India |
|
11 |
16 02 2026 |
EMA recommends withdrawal of marketing authorisations for levamisole medicines |
Pharmabiz |
India |
|
12 |
16 02 2026 |
Entod Pharmaceuticals unveils AI bio-engineered collagen skin serum |
Pharmabiz |
India |
|
13 |
16 02 2026 |
Lupin inks license & supply agreement with Spektus to commercialize novel antidepressant DeslaFlex in Canada |
Pharmabiz |
India |
|
14 |
16 02 2026 |
Government sets up TANUH at IISc to advance AI-driven healthcare innovation |
Pharmabiz |
India |
|
15 |
16 02 2026 |
Bulk drugs import declines 3.75% in first nine months of FY26 |
Pharmabiz |
India |
|
16 |
30 01 2026 |
India-EU FTA could reduce drug prices by upto 20% transform access to Biologics and Devices |
Medical Dialogues |
India |
|
17 |
30 01 2026 |
India’s OTC drugs market set to hit ₹98,000 Crore by 2030: EY Parthenon Report |
Express Pharma |
India |
|
18 |
30 01 2026 |
Health Ministry to reduce regulatory burden and promote ease of doing pharma business |
Biospetrum |
India |
|
19 |
30 01 2026 |
Government Sets Minimum Import Prices on Key Pharma Inputs to Counter Cheap Imports |
India me today |
India |
|
20 |
30 01 2026 |
Medical devices sector hopes India-EU FTA to be beneficial to the industry |
Pharmabiz |
India |
